Showing results (31-40 of 90) with videos related to
Sort By:
Pageof 9
Cancer Treatment Reports|October 1, 1986
Central nervous system toxicity of fludarabine phosphateH G Chun, B R Leyland-Jones, S M Caryk, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
Hypersensitivity reactions to deoxycoformycinP J O'Dwyer, S A King, E Eisenhauer, et al.Statistics in Medicine|May 1, 1992
k-ratio t tests for multiple comparisons involving several treatments and a controlL J Brant, D B Duncan, D O DixonToxicologic Pathology|January 1, 1985
Orally induced adjuvant-like arthritis in the ratJ E Gray, E R Larsen, P E Fast, et al.Immunopharmacology|October 1, 1982
Membrane fluidity and cholesterol in thymus and spleen cells from mice treated with immunomodulatory drugsM V Merritt, N J Licht, C A Hatfield, et al.Cancer Treatment Reports|July 1, 1987
Azacitidine: 10 years laterA B Glover, B R Leyland-Jones, H G Chun, et al.Oncology (Williston Park, N.Y.)|June 1, 1988
Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemiaP J O'Dwyer, B D Cheson, B Leyland-Jones, et al.Investigational New Drugs|December 1, 1988
Pyrazole: preclinical reassessmentP J O'Dwyer, S A King, J Plowman, et al.Annals of Internal Medicine|May 1, 1988
2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drugP J O'Dwyer, B Wagner, B Leyland-Jones, et al.Journal of the American Dental Association (1939)|February 1, 1979
The caries-preventive effect of amine fluorides and inorganic fluorides in a mouthrinse or dentifrice after 30 months of useM L Ringelberg, D B Webster, D O Dixon, et al.Pageof 9